The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 13,860 | 7,000,000 | SH | SOLE | 7,000,000 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 1,884 | 251,235 | SH | SOLE | 251,235 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 8,708 | 3,143,773 | SH | SOLE | 3,143,773 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 13,192 | 8,853,763 | SH | SOLE | 8,853,763 | 0 | 0 | ||
| AMRYT PHARMA PLC - SPNR ADR | SPONSORED ADS | 03217L106 | 44,025 | 6,298,348 | SH | SOLE | 6,298,348 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 854 | 28,800 | SH | SOLE | 28,800 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 7,891 | 2,161,999 | SH | SOLE | 2,161,999 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 102 | 208,443 | SH | SOLE | 208,443 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 6,122 | 17,304,350 | SH | SOLE | 17,304,350 | 0 | 0 | ||
| CASTLE BIOSCIENCES INC | COM | 14843C105 | 6,483 | 295,372 | SH | SOLE | 295,372 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 21,977 | 3,681,195 | SH | SOLE | 3,681,195 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 2,376 | 1,176,344 | SH | SOLE | 1,176,344 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 8,944 | 100,244 | SH | SOLE | 100,244 | 0 | 0 | ||
| ATYR PHARMA INC | COM NEW | 002120202 | 1,702 | 601,580 | SH | SOLE | 601,580 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 1,173 | 242,327 | SH | SOLE | 242,327 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 1,826 | 152,278 | SH | SOLE | 152,278 | 0 | 0 | ||
| OPTINOSE INC | COM | 68404V100 | 9,576 | 2,616,515 | SH | SOLE | 2,616,515 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 7,499 | 3,487,928 | SH | SOLE | 3,487,928 | 0 | 0 | ||
| QUIDELORTHO CORP | COM | 219798105 | 11,641 | 119,787 | SH | SOLE | 119,787 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 9,696 | 3,001,926 | SH | SOLE | 3,001,926 | 0 | 0 | ||
| SYNLOGIC INC | COM | 87166L100 | 107 | 92,746 | SH | SOLE | 92,746 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 9,099 | 1,111,050 | SH | SOLE | 1,111,050 | 0 | 0 | ||
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 17,937 | 11,647,417 | SH | SOLE | 11,647,417 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 7,235 | 1,260,387 | SH | SOLE | 1,260,387 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 1,023 | 45,910 | SH | SOLE | 45,910 | 0 | 0 | ||